No picture, placeholder image
No picture, placeholder image
Eksperimentell og klinisk farmakologi anne.orbo@uit.no

Anne Ørbo


Professor emerita


  • Natalia Smaglyukova, Elise Thoresen Sletten, Anne Ørbo, Georg Sager :
    Data on RT-qPCR assay of nuclear progesterone receptors (nPR), membrane progesterone receptors (mPR) and progesterone receptor membrane components (PGRMC) from human uterine endometrial tissue and cancer cells of the uterine cervix
    Data in Brief 2020 ARKIV / DOI
  • Elise Thoresen Sletten, Natalia Smaglyukova, Anne Ørbo, Georg Sager :
    Expression of nuclear progesterone receptors (nPR), membrane progesterone receptors (mPR) and progesterone receptor membrane components (PGRMC) in the human endometrium after 6 months levonorgestrel low dose intrauterine therapy,
    Journal of Steroid Biochemistry and Molecular Biology 2020 ARKIV / DOI
  • Elise Thoresen Sletten, Marit Arnes, Lena Marianne Myreng Lyså, Marthe Larsen, Anne Ørbo :
    Significance of progesterone receptors (PR-A and PR-B) expression as predictors for relapse after successful therapy of endometrial hyperplasia: a retrospective cohort study
    BJOG: An International Journal of Obstetrics and Gynaecology 2019 ARKIV / DOI
  • Elise Thoresen Sletten, Marit Arnes, Anne Beate Vereide, Anne Ørbo :
    Intrauterine progestin therapy as a new approach to premalignant endometrial polyps: A prospective observational study
    Anticancer Research 2019 ARKIV / DOI
  • Elise Thoresen Sletten, Marit Arnes, Anne Beate Vereide, Anne Ørbo :
    Low-dose LNG-IUS as therapy for endometrial hyperplasia. A prospective cohort pilot study
    Anticancer Research 2018 DOI
  • Elise Thoresen Sletten, Marit Arnes, Lena Marianne Myreng Lyså, Bjørn Thorvald Greve Moe, Bjørn Straume, Anne Ørbo :
    Prediction of relapse after therapy withdrawal in women with endometrial hyperplasia: A long-term follow-up study
    Anticancer Research 2017 DOI
  • Anne Ørbo, Marit Arnes, Lena Marianne Myreng Lyså, Christer Borgfelt, Bjørn Straume :
    HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
    British Journal of Cancer 2016 ARKIV / DOI
  • Anne Ørbo, Marit Arnes, Anne Beate Vereide, Bjørn Straume :
    Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens
    BJOG: An International Journal of Obstetrics and Gynaecology 2016 ARKIV / DOI
  • Anne Ørbo, Marit Arnes, Lena Marianne Myreng Lyså, Bjørn Straume :
    Expression of PAX2 and PTEN correlates to therapy response in endometrial hyperplasia
    Anticancer Research 2015 FULLTEKST / DOI
  • Anne Ørbo, Anne Beate Vereide, Marit Arnes, Inger Pettersen, Bjørn Straume :
    Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: A national multicentre randomised trial
    BJOG: An International Journal of Obstetrics and Gynaecology 2014 ARKIV / DOI
  • Marit Arnes, Bodil Hvingel, Anne Ørbo :
    Levonorgestrel-impregnated intrauterine device reduces occurrence of hyperplastic polyps: A population-based follow-up cohort study
    Anticancer Research 2014 DOI
  • Bodil Hvingel, Marit Lieng, Borghild Roald, Anne Ørbo :
    Vascular markers CD31, CD34, actin, VEGFB, and VEGFR2, are prognostic markers for malignant development in benign endometrial polyps
    Open Journal of Obstetrics and Gynecology 2012 DOI
  • Tormod Eggen, Georg Sager, Thomas Berg, Birgitte Nergaard, Bjørn Torvald Greve Moe, Anne Ørbo :
    Increased Gene Expression of the ABCC5 Transporter without Distinct Changes in the Expression of PDE5 in Human Cervical Cancer Cells during Growth
    Anticancer Research 2012 FULLTEKST
  • Tormod Eggen, Georg Sager, Marit Arnes, Inger Pettersen, Anne Ørbo :
    Expression of iNOS - A Favourable Prognostic Marker for Early-stage Carcinoma of the Uterine Cervix
    Anticancer Research 2011
  • Anne Ørbo, Bjørn Torvald Greve Moe, Marit Arnes, Inger Pettersen, Kari Margrethe Larsen, Tormod Eggen et al.:
    Prognostic markers for detection of coexistent carcinoma in high-risk endometrial hyperplasia
    Anticancer Research 2010
  • Anne Ørbo, Marit Arnes, Inger Pettersen, Kurt Larsen, Karin Johanne Hanssen, Bjørn Torvald Greve Moe :
    Down-regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system
    Acta Obstetricia et Gynecologica Scandinavica 2010 DOI
  • Renathe Fjelldal, Bjørn Torvald Greve Moe, Anne Ørbo, Georg Sager :
    MCF-7 Cell Apoptosis and Cell Cycle Arrest: Non-genomic Effects of Progesterone and Mifepristone (RU-486)
    Anticancer Research 2010
  • Bjørn Torvald Greve Moe, Anne Beate Vereide, Anne Ørbo, ragnhild JÆger, Georg Sager :
    Levonorgestrel, Medroxyprogesterone and Progesterone Cause a Concentration-dependent Reduction in Endometrial Cancer (Ishikawa) Cell Density, and High Concentrations of Progesterone and Mifepristone Act in Synergy
    Anticancer Research 2009
  • Anne Ørbo, Bjørn Torvald Greve Moe, Halvor Grønaas, Ruth H Paulssen :
    Early effects of high concentrations of progesterone and Mifepristone. A gene expression study of endometrial cancer cells (ishikawa)
    Journal of Steroid Biochemistry and Molecular Biology 2009 DOI
  • Bjørn Torvald Greve Moe, Anne Beate Vereide, Anne Ørbo, Georg Sager :
    High Concentrations of Progesterone and Mifepristone Mutually Reinforce Cell Cycle Retardation and Induction of Apoptosis
    Anticancer Research 2009
  • Anne Ørbo, marit Arnes, Christine Hancke, Anne Beate Vereide, Inger Pettersen, Kurt Larsen :
    Treatment results of endometrial hyperplasia after prospective D-score classification - A follow-up study comparing effect of LNG-IUD and oral progestins versus observation only
    Gynecologic Oncology 2008 DOI
  • Ruth H Paulssen, Bjørn Moe, Halvor Grønaas, Anne Ørbo :
    Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone
    Steroids 2008 DOI
  • Ruth H Paulssen, Bjørn Moe, Halvor Grønaas, Anne Ørbo :
    Gene expression in endometrial cancer cells (Ishikawa)after short time high exposure to progesterone
    Steroids 2008 DOI
  • Anne Ørbo, Målfrid Hanevik, ragnhild JÆger, Saskia Van Heusden, Georg Sager :
    Urinary cyclic GMP after treatment of gynecological cancer. A prognostic marker of clinical outcome
    Anticancer Research 2007
  • Tormod Eggen, Marit Arnes, Bjørn greve Moe, Bjørn Straume, Pia Marika Østman, Anne Ørbo :
    Prognosis of early cervical cancer (FIGO stages IA2, IB, and IIA) in Northern Norway predicted by malignancy grading score and objective morphometric image analysis
    International Journal of Gynecological Pathology 2007 DOI
  • Morten R. Høyning, Anne Ørbo :
    Prevensjonsmiddel vil hindre kreft hos tusenvis av kvinner
    17. December 2013
  • Eirik Linaker Berglund, Anne Ørbo :
    UiT-forsker i spissen for kreftsensasjon
    16. December 2013
  • Anne Ørbo :
    Spiral hindrer kreft
    18. December 2013
  • Anne Ørbo, Signe Tynning :
    Forskjellig bruk av hormonspiral
    30. January 2013
  • Morten R. Høyning, Anne Ørbo :
    Vil hindre kreft - Tusenvis av kvinner kan få hjelp av prevensjonsmiddel
    18. December 2013
  • Eirik Linaker Berglund, Anne Ørbo :
    Ny forskning slår fast: P-spiral stopper livmorkreften
    16. December 2013
  • Bjørn Thorvald Greve Moe, Anne Ørbo, Georg Sager, Anne Beate Vereide :
    Extranuclear steroid-initiated signaling by progestin and mifepristone: concentration-dependent inhibition of Ishikawa cell proliferation and induction of apoptosis
    Virchows Archiv 2011
  • Anne Ørbo, marit Arnes, Inger Pettersen, Kurt Larsen, Karin Johanne Hanssen, Bjørn Torvald Greve Moe :
    Successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system coincides with down-regulated progesterone receptor A and B
    Virchows Archiv 2011
  • Anne Ørbo, B Moe, I Pettersen, M Arnes, K Hanssen :
    Diagnostics of coexistent endometrial carcinoma in high-risk endometrial hyperplasia: significance of the 4c-rule and EIN for outcome prediction
    Virchows Archiv 2011
  • Anne Ørbo, Bjørn greve Moe, Georg Sager, Anne Beate Vereide :
    Extranuclear steroid-initiated signaling by progestin and mifepristone
    2007
  • Anne Ørbo :
    Bakgrunn for Levonovastsudien
    2007
  • Anne Ørbo, Christine Hancke :
    Status for prospektiv randomisert nasjonal studie (RCT) om behandling av forstadier til livmorkreft - Levonovastudien
    2007
  • Anne Ørbo :
    Lichen sclerosus / diagnostikk og behandling Årsmøte NNFOG Stokmarknes , 19-21 april 2007
    2007
  • Anne Ørbo :
    Uavklarte tilstander ved cervixcytologi Årsmøte NNFOG Stokmarknes, 19- april 2007
    2007
  • Anne Ørbo :
    Fra forskning til klnisk praksis, Årsmøte NNFOG Stokmarknes , 19-21 april 2007
    2007
  • Anne Ørbo, Marit Arnes, Inger Pettersen, Kurt Larsen :
    A study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone as treatment for endometrial hyperplasia. Assessment by light microscopy and morphometry
    2007
  • Anne Ørbo, Turid Kaino, Georg Sager, Marit Arnes :
    Bcl-2, BAX and apoptosis in endometrial hyperplasia after high dose gestagen therapy A comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone
    2007
  • Tormod Eggen, Marit Arnes, Bjørn greve Moe, Anne Ørbo :
    Prognosis of squamous cell carcinoma (Figo stage Ia2, Ib and IIa) of the uterine cervix predicted by malignancy grading score evaluation
    2007
  • Anne Ørbo :
    Kan man forebygge utvikling av livmorkreft
    2007
  • Anne Ørbo :
    Årsrapport - kunnskapscelle for gynekologisk onkologi/gynekologisk patologi-2006
    2007
  • Ruth H Paulssen, Bjørn Moe, Halvor Grønaas, Anne Ørbo :
    Gene expression in endometrial cancer cells (ishikawa) after short time high dose exposure to progestins
    Virchows Archiv 2007
  • Anne Ørbo :
    Hormonspiral kan forhindre livmorkreft
    22. June 2006
  • Anne Ørbo, Anne Beate Vereide :
    Status for levonovastudien
    2006
  • Anne Ørbo :
    Kompetansesenter for gynekologisk onkologi- Klinikk og patologi
    2006
  • Anne Ørbo, Tormod Eggen :
    Cervixcancer- nye prognostiske markører
    2006

  • The 50 latest publications is shown on this page. See all publications in Cristin here →